|
17/02/2025
|
07:00
|
£2m hMPV characterisation study contract
|
RNS
|
|
05/02/2025
|
07:00
|
Shionogi reports positive RSV trial results
|
RNS
|
|
03/02/2025
|
07:00
|
RSV contract signed with Inhalon Biopharma
|
RNS
|
|
31/01/2025
|
13:24
|
Holding(s) in Company
|
RNS
|
|
31/01/2025
|
07:00
|
Holding(s) in Company
|
RNS
|
|
29/01/2025
|
07:01
|
Acquisition: two Clinical Research Units from CRS
|
RNS
|
|
29/01/2025
|
07:00
|
Trading update
|
RNS
|
|
27/01/2025
|
07:00
|
LOI signed for Phase 3 Whooping Cough trial
|
RNS
|
|
21/01/2025
|
07:00
|
£3.2m hLAB project
|
RNS
|
|
14/01/2025
|
07:00
|
Holding(s) in Company
|
RNS
|
|
13/01/2025
|
07:00
|
hMPV challenge model update
|
RNS
|
|
10/12/2024
|
07:00
|
£11.5m RSV contract and notice of trading update
|
RNS
|
|
19/11/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
06/11/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
11/10/2024
|
07:00
|
Long Term Incentive Plan/ PDMR Notification
|
RNS
|
|
24/09/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
17/09/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
13/09/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
10/09/2024
|
07:00
|
Interim results
|
RNS
|
|
05/09/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
20/08/2024
|
07:00
|
Notice of results
|
RNS
|
|
06/08/2024
|
15:07
|
Holding(s) in Company
|
RNS
|
|
05/08/2024
|
07:00
|
Euronext cancellation
|
RNS
|
|
24/07/2024
|
13:55
|
Holding(s) in Company
|
RNS
|
|
23/07/2024
|
14:48
|
Director/PDMR Shareholding
|
RNS
|
|
17/07/2024
|
07:00
|
Trading update
|
RNS
|
|
17/07/2024
|
07:01
|
Holding(s) in Company
|
RNS
|
|
08/07/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
03/07/2024
|
14:48
|
Holding(s) in Company
|
RNS
|
|
02/07/2024
|
07:02
|
Change of registered address
|
RNS
|
|
02/07/2024
|
07:00
|
Influenza 2b field study contract
|
RNS
|
|
02/07/2024
|
07:01
|
Capital Markets Day & Notice of trading update
|
RNS
|
|
03/06/2024
|
07:00
|
£2.5m contract for Omicron characterisation study
|
RNS
|
|
13/05/2024
|
13:02
|
Result of AGM
|
RNS
|
|
15/04/2024
|
07:00
|
Annual Report & Notice of AGM
|
RNS
|
|
09/04/2024
|
07:09
|
Final results
|
RNS
|
|
27/03/2024
|
07:00
|
Notice of Results
|
RNS
|
|
22/03/2024
|
15:03
|
Holding(s) in Company
|
RNS
|
|
14/03/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
15/02/2024
|
07:00
|
Long Term Incentive Plan / PDMR Notification
|
RNS
|
|
14/02/2024
|
13:14
|
Result of Secondary Placing
|
RNS
|
|
14/02/2024
|
07:00
|
Proposed Secondary Placing of Ordinary Shares
|
RNS
|
|
02/02/2024
|
12:44
|
Holding(s) in Company
|
RNS
|
|
30/01/2024
|
07:00
|
Trading update
|
RNS
|
|
08/01/2024
|
07:00
|
Broker change
|
RNS
|
|
02/01/2024
|
07:00
|
£6.3m HRV contract signed with biotech client
|
RNS
|
|
13/12/2023
|
07:00
|
£16.8m RSV contract & Trading ahead of guidance
|
RNS
|
|
12/09/2023
|
07:00
|
Interim results
|
RNS
|
|
01/09/2023
|
07:00
|
Exercise of Warrants
|
RNS
|
|
29/08/2023
|
07:00
|
Plans for a new larger state-of-the-art facility
|
RNS
|